Original
Persistencia al tratamiento con metformina de marca vs. genérica en monoterapia para la diabetes tipo 2: estudio retrospectivo de vida real mediante propensity score matching
Treatment persistence with brand-name vs. generic metformin in monotherapy for type 2 diabetes: real-life retrospective study using the propensity matching score
A. Sicras-Mainar
, A. Sicras-Navarro
Autor para correspondencia
Dirección científica, Atrys Health, Barcelona, España
Leído
35439
Vecesse ha leído el artículo
1032
Total PDF
34407
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 149 | 18 | 167 |
| 2025 11 | 765 | 59 | 824 |
| 2025 10 | 866 | 38 | 904 |
| 2025 9 | 1108 | 56 | 1164 |
| 2025 8 | 1027 | 64 | 1091 |
| 2025 7 | 1013 | 47 | 1060 |
| 2025 6 | 967 | 46 | 1013 |
| 2025 5 | 1096 | 27 | 1123 |
| 2025 4 | 896 | 23 | 919 |
| 2025 3 | 1047 | 26 | 1073 |
| 2025 2 | 1027 | 20 | 1047 |
| 2025 1 | 974 | 25 | 999 |
| 2024 12 | 852 | 19 | 871 |
| 2024 11 | 984 | 25 | 1009 |
| 2024 10 | 1123 | 32 | 1155 |
| 2024 9 | 1191 | 41 | 1232 |
| 2024 8 | 1119 | 29 | 1148 |
| 2024 7 | 1001 | 23 | 1024 |
| 2024 6 | 824 | 8 | 832 |
| 2024 5 | 982 | 18 | 1000 |
| 2024 4 | 1243 | 32 | 1275 |
| 2024 3 | 952 | 17 | 969 |
| 2024 2 | 947 | 24 | 971 |
| 2024 1 | 858 | 18 | 876 |
| 2023 12 | 718 | 14 | 732 |
| 2023 11 | 751 | 20 | 771 |
| 2023 10 | 903 | 11 | 914 |
| 2023 9 | 696 | 6 | 702 |
| 2023 8 | 692 | 2 | 694 |
| 2023 7 | 706 | 27 | 733 |
| 2023 6 | 642 | 8 | 650 |
| 2023 5 | 781 | 8 | 789 |
| 2023 4 | 494 | 14 | 508 |
| 2023 3 | 797 | 25 | 822 |
| 2023 2 | 536 | 5 | 541 |
| 2022 1 | 455 | 12 | 467 |
| 2022 12 | 273 | 11 | 284 |
| 2022 11 | 511 | 15 | 526 |
| 2022 10 | 433 | 15 | 448 |
| 2022 9 | 481 | 8 | 489 |
| 2022 8 | 397 | 11 | 408 |
| 2022 7 | 273 | 9 | 282 |
| 2022 6 | 201 | 12 | 213 |
| 2022 5 | 165 | 8 | 173 |
| 2022 4 | 201 | 15 | 216 |
| 2022 3 | 138 | 14 | 152 |
| 2022 2 | 71 | 8 | 79 |
| 2021 1 | 52 | 8 | 60 |
| 2021 12 | 3 | 1 | 4 |
| 2021 11 | 3 | 0 | 3 |
| 2021 9 | 9 | 10 | 19 |
| 2021 8 | 9 | 0 | 9 |
| 2021 7 | 5 | 0 | 5 |
Mostrar todo
